CORRESP Filing
ARTELO BIOSCIENCES, INC.
Date: April 13, 2026 · CIK: 0001621221 · Accession: 0001640334-26-000693
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294912
Letter
artl_corresp.htm
Artelo Biosciences, Inc.
505 Lomas Santa Fe, Suite 160
Solana Beach, CA 92075
April 13, 2026
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC. 20549
Attn: Doris Stacey Gama
Re:
Artelo Biosciences, Inc.
Registration Statement on Form S-1 (File No. 333-294912)
Ladies and Gentlemen,
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Wednesday, April 15, 2026, or as soon thereafter as practicable.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100.
Respectfully,
Artelo Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
artl_corresp.htm
Artelo Biosciences, Inc.
505 Lomas Santa Fe, Suite 160
Solana Beach, CA 92075
April 13, 2026
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC. 20549
Attn: Doris Stacey Gama
Re:
Artelo Biosciences, Inc.
Registration Statement on Form S-1 (File No. 333-294912)
Ladies and Gentlemen,
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Wednesday, April 15, 2026, or as soon thereafter as practicable.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100.
Respectfully,
Artelo Biosciences, Inc.
By: /s/ Gregory D. Gorgas
Gregory D. Gorgas
Chief Executive Officer
cc: Louis A. Bevilacqua, Esq.